Navigation Links
BELLUS Health reports results for first quarter of fiscal 2009
Date:5/6/2009

LAVAL, QC, May 6 /PRNewswire-FirstCall/ - BELLUS Health Inc. ("BELLUS Health" or the "Company") (TSX: BLU) reported results for the first quarter ended March 31, 2009. The Company reported a net loss of $9,907,000 ($0.20 per share) for the quarter, compared to $13,042,000 ($0.27 per share) for the same period the previous year. The decrease in the net loss is mainly due to a reduction in research and development (R&D) expenses, before research tax credits and grants, which amounted to $3,610,000 for the current quarter, compared to $8,780,000 for the same period the previous year. The decrease is mainly attributable to a reduction in the research and development of tramiprosate (ALZHEMED(TM); homotaurine) for the treatment of Alzheimer's disease following the Company's decision in November 2007 to terminate the tramiprosate (ALZHEMED(TM)) pharmaceutical drug development program. The Company is also developing NC-503 (eprodisate) for the treatment of Type II diabetes and certain features of metabolic syndrome.

As at March 31, 2009, the Company had available cash, cash equivalents and marketable securities of $3,187,000, compared to $10,595,000 at December 31, 2008. The decrease is primarily due to funds used in operating activities.

On April 16, after the end of the first quarter of 2009, the Company announced the completion of the first tranche of its previously announced $20.5 million CAD convertible notes (see Liquidity and capital resources section for further details). BELLUS Health received gross proceeds of $10 million CAD for the issuance of new convertible notes. A second tranche of $10.5 million CAD is expected to be funded by June 2009. In March 2009, the Company announced a reduction in the workforce and other related measures which are expected to result in annual savings of approximately $3.5 million CAD, and the restructuring of the lease of the Company's main premises and the 2006 and 2007 convertible notes, which are expect
'/>"/>

SOURCE BELLUS HEALTH INC.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

Related medicine news :

1. BELLUS announces Chief Financial Officer to depart effective May 22, 2009
2. BELLUS Health inc. announces completion of first tranche of financing
3. BELLUS Health reports results for the fourth quarter of 2008
4. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc.
5. BELLUS Health announces formal notice to voluntarily delist from NASDAQ
6. BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capital Market
7. BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
8. BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
9. BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
10. BELLUS Health provides update on activities
11. BELLUS Health announces closing of Innodia acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... A new AlignLife Chiropractic & Natural Health ... Greenville area. Dr. Chelsea Sineath, owner and chiropractor at ... her own clinic after working in another AlignLife office ... , AlignLife believes that the body can heal itself ... chiropractic care and rehabilitation to allow the spine to ...
(Date:11/22/2014)... November 23, 2014 PrettyTailor , ... with a new big promotion. Customers can buy new ... information, customers can visit its website. , As a ... and occasion dresses. It mainly provides four types of ... dresses and flower girl dresses. It also provides a ...
(Date:11/22/2014)... black prom dress will never go out of fashion. BellasDress.com, ... new items of black prom gowns . Now all ... up to 70% off. People throughout the world can enjoy ... made with the best materials, can make wearers feel comfortable. ... company provides these beautiful outfits in a huge range of ...
(Date:11/22/2014)... 2014 BambooFlooringChina.com is a famous ... proudly released its new collection of bamboo mats ; ... to 29% off. , According to the sales ... grass, making it a highly renewable resource. Their bamboo mats ... mixing color which comes from natural bamboo with caramel bamboo ...
(Date:11/22/2014)... New York, NY (PRWEB) November 22, 2014 ... Australia’s Therapeutics Goods Administration (TGA) approved it for ... Glutathione was approved and listed within the Therapeutic ... http://www.comlaw.gov.au/Details/F2014L01277 , Kyowa Hakko’s Setria® Glutathione ... Chem, a biotech specialist that sources and imports ...
Breaking Medicine News(10 mins):Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3
... rebuilding teams responding to the devastation across Greece caused ... space. A series of crisis map products based on ... aid damage assessment efforts following the activation of the ... than 60 people were killed and thousands left homeless ...
... 21 Baxa Corporation, a leading,provider of systems ... announces the addition of two new international product,distributors. ... Colombia and Pentafarma & Co. in The Dominican ... reach and expand product promotion in South,America and ...
... in Series A Funding from DCM and Split Rock ... today announced,the beta availability of its website. Caring.com will ... experts, helpful information,and resources, and a community of people ... the more than 34 million adults who are,caring for ...
... selected by high-level scientific peer review, will gather in Helsinki ... as 1.2 million from the fourth and final Call of ... allow the researchers to create teams in Europe to focus ... outstanding young scientists from around the world to create their ...
... plus insulin works best, researchers say , , FRIDAY, Sept. ... which insulin-plus-drug regimen might best control type 2 diabetes ... three strategies tested coming out on top. , "What ... the study can be recommended" as being superior to ...
... Brandeis neuroscientist Gina Turrigiano has been awarded a National ... grant totaling $2.5 million. She is one of 12 ... , According to NIH, the award is designed to ... approaches to major challenges in biomedical and behavioral research. ...
Cached Medicine News:Health News:Greeks get space-based help in wake of deadly fires 2Health News:Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 2Health News:New Resource for Taking Care of Aging Parents Available in Beta 2Health News:New Resource for Taking Care of Aging Parents Available in Beta 3Health News:2007 EURYI: 20 researchers to receive Nobel Prize-sized awards in Helsinki 2Health News:2007 EURYI: 20 researchers to receive Nobel Prize-sized awards in Helsinki 3Health News:No Clear Winner in Diabetes Treatment Trial 2Health News:No Clear Winner in Diabetes Treatment Trial 3
(Date:11/22/2014)... 22, 2014  New data demonstrates that flibanserin, a ... form of female sexual dysfunction, Hypoactive Sexual Desire Disorder ... performance in premenopausal women when taken at bedtime. The ... North America,s (SMSNA) 20th Annual ... SMSNA accepted this study as a ...
(Date:11/22/2014)... , Nov. 21, 2014   Long Beach dentist , ... often called the gold standard in tooth replacement because they ... stable, long-lasting way to restore and preserve smiles and improve ... replace a missing tooth or as a part of a ... look and feel of a smile. The loss ...
(Date:11/22/2014)... 21, 2014  Particle Sciences, Inc (PSI), the ... and manufactured a new innovative vaginal ring for ... Development arm of Exeltis Pharmaceuticals.  According to ... at Particle Sciences, "This vaginal ring was developed ... sciences and modeling expertise.  We are thrilled it ...
Breaking Medicine Technology:Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2